FXR314 well tolerated, lowers liver fat, Phase 2 MASH trial shows
FXR314, an investigational oral therapy, safely and effectively reduced liver fat content in adults with a severe form of fatty liver disease called metabolic…
Fatty liver disease is a term used to refer to a group of disorders characterized by abnormal amounts of fat in the liver. Together, these diseases are estimated to affect more than one-third of people in the U.S. and other industrialized countries.
Read moreFatty liver disease treatment approaches will depend on the condition’s exact cause. But patients are generally encouraged to make lifestyle changes, such as diet and exercise, that aim to promote weight loss and reduce the amount of fat in the body.
Read moreFXR314, an investigational oral therapy, safely and effectively reduced liver fat content in adults with a severe form of fatty liver disease called metabolic…
The approval of Rezdiffra (resmetirom) last month in the U.S. as the first ever treatment for nonalcoholic steatohepatitis (NASH), a severe type of…